Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
GRANULES INDIA ADCOCK INGRAM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GRANULES INDIA Mar-23 |
ADCOCK INGRAM Jun-14 |
GRANULES INDIA/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 381 | 314 | - | |
Low | Rs | 227 | 226 | - | |
Sales per share (Unadj.) | Rs | 186.4 | 93.4 | - | |
Earnings per share (Unadj.) | Rs | 21.3 | -23.5 | - | |
Cash flow per share (Unadj.) | Rs | 29.0 | -19.5 | - | |
Dividends per share (Unadj.) | Rs | 1.50 | 0 | - | |
Avg Dividend yield | % | 0.5 | 0 | - | |
Book value per share (Unadj.) | Rs | 116.4 | 73.3 | - | |
Shares outstanding (eoy) | m | 242.04 | 168.78 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.6 | 2.9 | 56.4% | |
Avg P/E ratio | x | 14.2 | -11.5 | -124.1% | |
P/CF ratio (eoy) | x | 10.5 | -13.9 | -75.8% | |
Price / Book Value ratio | x | 2.6 | 3.7 | 70.9% | |
Dividend payout | % | 7.0 | 0 | - | |
Avg Mkt Cap | Rs m | 73,611 | 45,603 | 161.4% | |
No. of employees | `000 | NA | 4.3 | 0.0% | |
Total wages/salary | Rs m | 4,203 | 2,862 | 146.9% | |
Avg. sales/employee | Rs Th | 0 | 3,671.4 | - | |
Avg. wages/employee | Rs Th | 0 | 666.7 | - | |
Avg. net profit/employee | Rs Th | 0 | -925.1 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 45,119 | 15,761 | 286.3% | |
Other income | Rs m | 143 | 110 | 129.4% | |
Total revenues | Rs m | 45,262 | 15,872 | 285.2% | |
Gross profit | Rs m | 9,133 | -2,731 | -334.4% | |
Depreciation | Rs m | 1,845 | 680 | 271.2% | |
Interest | Rs m | 559 | 427 | 131.0% | |
Profit before tax | Rs m | 6,872 | -3,728 | -184.3% | |
Minority Interest | Rs m | 0 | -10 | -0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1,706 | 233 | 732.2% | |
Profit after tax | Rs m | 5,166 | -3,971 | -130.1% | |
Gross profit margin | % | 20.2 | -17.3 | -116.8% | |
Effective tax rate | % | 24.8 | -6.2 | -397.3% | |
Net profit margin | % | 11.4 | -25.2 | -45.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 25,741 | 11,544 | 223.0% | |
Current liabilities | Rs m | 18,135 | 6,495 | 279.2% | |
Net working cap to sales | % | 16.9 | 32.0 | 52.6% | |
Current ratio | x | 1.4 | 1.8 | 79.9% | |
Inventory Days | Days | 14 | 111 | 13.0% | |
Debtors Days | Days | 77 | 124 | 61.9% | |
Net fixed assets | Rs m | 23,290 | 6,729 | 346.1% | |
Share capital | Rs m | 242 | 73 | 330.8% | |
Net worth | Rs m | 28,169 | 12,371 | 227.7% | |
Long term debt | Rs m | 1,486 | 4,347 | 34.2% | |
Total assets | Rs m | 49,031 | 23,369 | 209.8% | |
Interest coverage | x | 13.3 | -7.7 | -171.8% | |
Debt to equity ratio | x | 0.1 | 0.4 | 15.0% | |
Sales to assets ratio | x | 0.9 | 0.7 | 136.4% | |
Return on assets | % | 11.7 | -15.2 | -77.0% | |
Return on equity | % | 18.3 | -32.1 | -57.1% | |
Return on capital | % | 25.1 | -19.8 | -126.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 7,387 | 1,345 | 549.1% | |
From Investments | Rs m | -1,914 | -413 | 463.3% | |
From Financial Activity | Rs m | -4,403 | 3,945 | -111.6% | |
Net Cashflow | Rs m | 1,068 | 4,878 | 21.9% |
Compare GRANULES INDIA With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare GRANULES INDIA With: AMI ORGANICS TORRENT PHARMA WANBURY WINDLAS BIOTECH BLUE JET HEALTHCARE
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.